Risa Hamada

Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Teppei Hagino, Risa Hamada, Mai Yoshida et al. · Clinical Cosmetic and Investigational Dermatology · 2023 · 24 citations · Full text

Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan

Teppei Hagino, Mai Yoshida, Risa Hamada et al. · Journal of Dermatological Treatment · 2023 · 22 citations · Full text

Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks

Teppei Hagino, Risa Hamada, Mai Yoshida et al. · Frontiers in Immunology · 2024 · 22 citations · Full text

Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with <scp>moderate‐to‐severe</scp> atopic dermatitis

Teppei Hagino, Mai Yoshida, Risa Hamada et al. · The Journal of Dermatology · 2023 · 21 citations · Full text

Allergy Medicine, Skin Allergy, Pharmacotherapy +17

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis

Teppei Hagino, Mai Yoshida, Risa Hamada et al. · Journal of Dermatological Treatment · 2024 · 18 citations · Full text